semaglutide weight loss medicine GLP-1 Weight Loss Drug Wegovy Can

We know that injections arent suitable for everyone, which is why we also offer oral medication for effective weight loss

Glucagon-like peptide-1 (GLP-1) receptor agonist Glucagon-like peptide-1 (GLP-1) receptor agonist Wegovy (semaglutide) is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbid condition Wegovy (semaglutide) is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbid condition Typically taken as an injection once weekly Comes in single-dose pens that deliver 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg per injection Typically taken as an injection once weekly Comes in single-dose pens that deliver 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg per injection Most common adverse reactions (incidence 5%) in adults or pediatric patients aged 12 years and older are: Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Indigestion Dizziness Abdominal distension Belching Low blood sugar in patients with type 2 diabetes Flatulence Inflammation of the digestive system Gastroesophageal reflux disease (heartburn) Inflammation of the nasal cavities and back of the throat Most common adverse reactions (incidence 5%) in adults or pediatric patients aged 12 years and older are: Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Indigestion Dizziness Abdominal distension Belching Low blood sugar in patients with type 2 diabetes Flatulence Inflammation of the digestive system Gastroesophageal reflux disease (heartburn) Inflammation of the nasal cavities and back of the throat Personal or family history of medullary thyroid carcinoma or in patients with multiple endocrine neoplasia syndrome type 2 Known hypersensitivity to semaglutide or any of the excipients in Wegovy Drug interactions: Wegovy delays gastric emptying

We have a wide selection of general medical supplies, including solutions for irrigation and injection, clear and amber vials, needles, syringes, personal protective equipment (PPE), disposables, OTC medication and much more

A product's actual identity, strength, sterility, and contaminants may also be unknown, making seller-specific risk claims unreliable

Cardiometabolic Health at Eli Lilly

How Glutathione Protects Cells from Oxidative Stress Oxidative stress is a contributing factor in numerous health issues, including cardiovascular diseases, neurodegenerative disorders, and certain cancers